InstitutionMD Anderson
DepartmentBreast Surgical Oncology
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thompson AM, Clements K, Cheung S, Pinder SE, Lawrence G, Sawyer E, Kearins O, Ball GR, Tomlinson I, Hanby A, Thomas JSJ, Maxwell AJ, Wallis MG, Dodwell DJ. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. Eur J Cancer. 2018 09; 101:210-219. PMID: 30092498.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. 2015 Oct; 1(7):931-41. PMID: 26247543.
      Citations: 40     Fields:    Translation:HumansPHPublic Health
    3. Rae JM, Leyland-Jones B, Regan M, Thompson AM. Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies. J Natl Cancer Inst. 2015 May; 107(5). PMID: 25814445.
      Citations: 2     Fields:    Translation:Humans
    4. Caudle AS, Thompson AM. Less remains better: morbidity after axillary surgery. Ann Surg Oncol. 2015 Jan; 22(1):4-6. PMID: 25047480.
      Citations:    Fields:    Translation:Humans
    5. Fraser DM, Sullivan FM, Thompson AM, McCowan C. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer. 2014 Jul 29; 111(3):623-7. PMID: 24945997.
      Citations: 37     Fields:    Translation:Humans
    6. Thomas J, Hanby A, Pinder SE, Ball G, Lawrence G, Maxwell A, Wallis M, Evans A, Dobson H, Clements K, Thompson A. Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. Eur J Cancer. 2014 Jul; 50(11):1880-90. PMID: 24874088.
      Citations: 1     Fields:    Translation:Humans
    7. Bouchalova P, Nenutil R, Muller P, Hrstka R, Appleyard MV, Murray K, Jordan LB, Purdie CA, Quinlan P, Thompson AM, Vojtesek B, Coates PJ. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. J Pathol. 2014 Jul; 233(3):238-46. PMID: 24687952.
      Citations: 7     Fields:    Translation:HumansCells
    8. Thompson AM. Molecular pathways: preclinical models and clinical trials with metformin in breast cancer. Clin Cancer Res. 2014 May 15; 20(10):2508-15. PMID: 24682417.
      Citations: 24     Fields:    Translation:HumansAnimals
    9. Liu Y, Nenutil R, Appleyard MV, Murray K, Boylan M, Thompson AM, Coates PJ. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014 Apr 15; 110(8):2063-71. PMID: 24577057.
      Citations: 35     Fields:    Translation:HumansCells
    10. Kirwan CC, Al Sarakbi W, Loncaster J, Chan HY, Thompson AM, Wishart GC. Tumour bed clip localisation for targeted breast radiotherapy: compliance is proportional to trial-related research activity: tumour bed clip localisation in breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):158-62. PMID: 24373297.
      Citations: 5     Fields:    Translation:Humans
    11. Elsberger B, Romsauerova A, Vinnicombe S, Whelehan P, Brown DC, Dewar JA, Thompson AM, Evans A. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163-7. PMID: 24332581.
      Citations: 3     Fields:    Translation:Humans
    12. Evans A, Rauchhaus P, Whelehan P, Thomson K, Purdie CA, Jordan LB, Michie CO, Thompson A, Vinnicombe S. Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer? Breast Cancer Res Treat. 2014 Jan; 143(1):153-7. PMID: 24305976.
      Citations: 16     Fields:    Translation:Humans
    13. Purdie CA, Quinlan P, Jordan LB, Ashfield A, Ogston S, Dewar JA, Thompson AM. Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer. 2014 Feb 04; 110(3):565-72. PMID: 24300977.
      Citations: 34     Fields:    Translation:Humans
    14. Rao B, Lain S, Thompson AM. p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy. Br J Cancer. 2013 Dec 10; 109(12):2954-8. PMID: 24231949.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    15. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014 Feb 15; 383(9917):603-13. PMID: 24224997.
      Citations: 159     Fields:    Translation:Humans
    16. Evans A, Armstrong S, Whelehan P, Thomson K, Rauchhaus P, Purdie C, Jordan L, Jones L, Thompson A, Vinnicombe S. Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? Br J Cancer. 2013 Nov 26; 109(11):2798-802. PMID: 24169359.
      Citations: 15     Fields:    Translation:Humans
    17. Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, Thompson AM, Cairns Smith W, Chambers WA, Scott NW. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014 Feb; 155(2):232-43. PMID: 24099954.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    18. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O'Connor JP, O'Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013 Oct 01; 15(5):R92. PMID: 24286369.
      Citations: 106     Fields:    Translation:HumansAnimals
    19. Province MA, Goetz MP, Brauch H, Flockhart DA, Hebert JM, Whaley R, Suman VJ, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman WG, Lee MT, Ambrosone CB, Beckmann MW, Choi JY, Dieudonné AS, Fasching PA, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan LB, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen AT, Park BW, Purdie CA, Quinlan P, Renner W, Schmidt M, Schwab M, Shin JG, Stingl JC, Wegman P, Wingren S, Wu AH, Ziv E, Zirpoli G, Thompson AM, Jordan VC, Nakamura Y, Altman RB, Ames MM, Weinshilboum RM, Eichelbaum M, Ingle JN, Klein TE. CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther. 2014 Feb; 95(2):216-27. PMID: 24060820.
      Citations: 48     Fields:    Translation:Humans
    20. Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonzàlez E, Vendrell JA, Hacot S, Mertani HC, Albaret MA, Bourdon JC, Jordan L, Thompson A, Tafer Y, Cong R, Bouvet P, Saurin JC, Catez F, Prats AC, Puisieux A, Diaz JJ. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell. 2013 Sep 09; 24(3):318-30. PMID: 24029231.
      Citations: 70     Fields:    Translation:HumansCells
    21. Young J, Thompson A, Tait I, Waugh L, McPhillips G. Centralization of services and reduction of adverse events in pancreatic cancer surgery. World J Surg. 2013 Sep; 37(9):2229-33. PMID: 23756771.
      Citations: 3     Fields:    Translation:Humans
    22. Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct; 24 Suppl 6:vi7-23. PMID: 23970019.
      Citations: 121     Fields:    Translation:Humans
    23. McCowan C, Wang S, Thompson AM, Makubate B, Petrie DJ. The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study. Br J Cancer. 2013 Sep 03; 109(5):1172-80. PMID: 23949153.
      Citations: 27     Fields:    Translation:Humans
    24. Young JA, Waugh L, McPhillips G, Steele RJ, Thompson AM. Use of the high dependency unit, increased consultant involvement and reduction in adverse events in patients who die after colorectal cancer surgery. Colorectal Dis. 2013 Jul; 15(7):824-9. PMID: 23375051.
      Citations:    Fields:    Translation:Humans
    25. Amaral T, McKenna SJ, Robertson K, Thompson A. Classification and immunohistochemical scoring of breast tissue microarray spots. IEEE Trans Biomed Eng. 2013 Oct; 60(10):2806-14. PMID: 23715601.
      Citations: 3     Fields:    Translation:Humans
    26. Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013 Apr 16; 108(7):1515-24. PMID: 23519057.
      Citations: 58     Fields:    Translation:Humans
    27. Lo Nigro C, Wang H, McHugh A, Lattanzio L, Matin R, Harwood C, Syed N, Hatzimichael E, Briasoulis E, Merlano M, Evans A, Thompson A, Leigh I, Fleming C, Inman GJ, Proby C, Crook T. Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma. J Invest Dermatol. 2013 May; 133(5):1278-85. PMID: 23407390.
      Citations: 13     Fields:    Translation:HumansCells
    28. Dayal JH, Sales MJ, Corver WE, Purdie CA, Jordan LB, Quinlan PR, Baker L, ter Haar NT, Pratt NR, Thompson AM. Multiparameter DNA content analysis identifies distinct groups in primary breast cancer. Br J Cancer. 2013 Mar 05; 108(4):873-80. PMID: 23412097.
      Citations: 3     Fields:    Translation:Humans
    29. Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C. Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. Ann Oncol. 2013 Mar; 24(3):647-54. PMID: 23337633.
      Citations: 35     Fields:    Translation:Humans
    30. Smith TA, Appleyard MV, Sharp S, Fleming IN, Murray K, Thompson AM. Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters. Cancer Chemother Pharmacol. 2013 Feb; 71(2):473-80. PMID: 23178956.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    31. Critchley AC, Thompson AM, Chan HY, Reed MW. Current controversies in breast cancer surgery. Clin Oncol (R Coll Radiol). 2013 Feb; 25(2):101-8. PMID: 23183307.
      Citations: 2     Fields:    Translation:Humans
    32. Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JÅ. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res. 2012 Nov 16; 14(6):R148. PMID: 23158001.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    33. Thompson AM. New standards of care in the management of the axilla. Curr Opin Oncol. 2012 Nov; 24(6):605-11. PMID: 22960559.
      Citations: 2     Fields:    Translation:Humans
    34. Young JA, Shimi SM, Waugh L, McPhillips G, Thompson AM. Improved short term surgical outcomes in Scotland for oesophageal cancer. Eur J Surg Oncol. 2013 Feb; 39(2):131-5. PMID: 23092691.
      Citations: 1     Fields:    Translation:Humans
    35. Pinder SE, Brown JP, Gillett C, Purdie CA, Speirs V, Thompson AM, Shaaban AM. The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example. J Clin Pathol. 2013 Mar; 66(3):169-77. PMID: 23087330.
      Citations: 12     Fields:    Translation:Humans
    36. Hatzimichael E, Lo Nigro C, Lattanzio L, Syed N, Shah R, Dasoula A, Janczar K, Vivenza D, Monteverde M, Merlano M, Papoudou-Bai A, Bai M, Schmid P, Stebbing J, Bower M, Dyer MJ, Karran LE, ElguetaKarstegl C, Farrell PJ, Thompson A, Briasoulis E, Crook T. The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma. Br J Cancer. 2012 Oct 09; 107(8):1423-32. PMID: 22955849.
      Citations: 5     Fields:    Translation:HumansCells
    37. Thompson AM, Moulder-Thompson SL. Neoadjuvant treatment of breast cancer. Ann Oncol. 2012 Sep; 23 Suppl 10:x231-6. PMID: 22987968.
      Citations: 32     Fields:    Translation:Humans
    38. Young JA, Waugh L, McPhillips G, Levack P, Thompson AM. Palliative care for patients with gastrointestinal cancer dying under surgical care: a case for acute palliative care units? Surgeon. 2013 Apr; 11(2):72-5. PMID: 22878097.
      Citations:    Fields:    Translation:Humans
    39. Bruce J, Thornton AJ, Scott NW, Marfizo S, Powell R, Johnston M, Wells M, Heys SD, Thompson AM. Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer. 2012 Sep 04; 107(6):937-46. PMID: 22850552.
      Citations: 14     Fields:    Translation:Humans
    40. Mackenzie IS, Macdonald TM, Thompson A, Morant S, Wei L. Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ. 2012 Jul 13; 345:e4447. PMID: 22797844.
      Citations: 12     Fields:    Translation:HumansAnimals
    41. Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, Thompson A, Garrone O, Merlano M, Lo Nigro C, Crook T. Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPd) CpG island in breast cancer is associated with metastatic relapse. Br J Cancer. 2012 Aug 07; 107(4):732-8. PMID: 22782348.
      Citations: 6     Fields:    Translation:HumansCells
    42. Westendorf AF, Woods JA, Korpis K, Farrer NJ, Salassa L, Robinson K, Appleyard V, Murray K, Grünert R, Thompson AM, Sadler PJ, Bednarski PJ. Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. . 2012 Sep; 11(9):1894-904. PMID: 22710878.
    43. Evans A, Whelehan P, Thomson K, Brauer K, Jordan L, Purdie C, McLean D, Baker L, Vinnicombe S, Thompson A. Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification. Br J Cancer. 2012 Jul 10; 107(2):224-9. PMID: 22691969.
      Citations: 44     Fields:    Translation:Humans
    44. Goodwin PJ, Thompson AM, Stambolic V. Diabetes, metformin, and breast cancer: lilac time? J Clin Oncol. 2012 Aug 10; 30(23):2812-4. PMID: 22689806.
      Citations: 12     Fields:    Translation:Humans
    45. Lo Nigro C, Monteverde M, Lee S, Lattanzio L, Vivenza D, Comino A, Syed N, McHugh A, Wang H, Proby C, Garrone O, Merlano M, Hatzimichael E, Briasoulis E, Gojis O, Palmieri C, Jordan L, Quinlan P, Thompson A, Crook T. NT5E CpG island methylation is a favourable breast cancer biomarker. Br J Cancer. 2012 Jun 26; 107(1):75-83. PMID: 22653144.
      Citations: 10     Fields:    Translation:HumansCells
    46. Thompson AM. Translational research: A UK tissue bank for breast tumours. Nature. 2012 May 09; 485(7397):174. PMID: 22575950.
      Citations: 1     Fields:    Translation:Humans
    47. Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J. Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. Br J Cancer. 2012 May 08; 106(10):1618-25. PMID: 22531635.
      Citations: 7     Fields:    Translation:Humans
    48. Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Baker L, Jordan L, Rauchhaus P, Thompson A. Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012 Jun; 263(3):673-7. PMID: 22523322.
      Citations: 56     Fields:    Translation:Humans
    49. Sturrock M, Terry AJ, Xirodimas DP, Thompson AM, Chaplain MA. Influence of the nuclear membrane, active transport, and cell shape on the Hes1 and p53-Mdm2 pathways: insights from spatio-temporal modelling. Bull Math Biol. 2012 Jul; 74(7):1531-79. PMID: 22527944.
      Citations: 8     Fields:    Translation:AnimalsCells
    50. Thompson AM, Newman TJ. Milking the stroma in triple-negative breast cancer. . 2012 Apr 15; 11(8):1487. PMID: 22544077.
    51. McCowan C, Thompson AM. The importance of nonpharmacogenetic factors in endocrine therapy. Pharmacogenomics. 2012 Apr; 13(6):721-8. PMID: 22515614.
      Citations: 4     Fields:    Translation:Humans
    52. Wang H, Lee S, Nigro CL, Lattanzio L, Merlano M, Monteverde M, Matin R, Purdie K, Mladkova N, Bergamaschi D, Harwood C, Syed N, Szlosarek P, Briasoulis E, McHugh A, Thompson A, Evans A, Leigh I, Fleming C, Inman GJ, Hatzimichael E, Proby C, Crook T. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity. Br J Cancer. 2012 Apr 10; 106(8):1446-52. PMID: 22454080.
      Citations: 26     Fields:    Translation:HumansCells
    53. Fong A, Shafiq J, Saunders C, Thompson AM, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy. Breast. 2012 Aug; 21(4):570-7. PMID: 22425535.
      Citations: 2     Fields:    Translation:Humans
    54. King SI, Purdie CA, Bray SE, Quinlan PR, Jordan LB, Thompson AM, Meek DW. Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom. Breast Cancer Res. 2012 Mar 08; 14(2):R40. PMID: 22405092.
      Citations: 35     Fields:    Translation:Humans
    55. Appleyard MV, Murray KE, Coates PJ, Wullschleger S, Bray SE, Kernohan NM, Fleming S, Alessi DR, Thompson AM. Phenformin as prophylaxis and therapy in breast cancer xenografts. Br J Cancer. 2012 Mar 13; 106(6):1117-22. PMID: 22361631.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    56. Aga H, Readhead D, Maccoll G, Thompson A. Fall in peptic ulcer mortality associated with increased consultant input, prompt surgery and use of high dependency care identified through peer-review audit. BMJ Open. 2012; 2(1):e000271. PMID: 22357569.
      Citations: 2     Fields:    
    57. Macklin P, Edgerton ME, Thompson AM, Cristini V. Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol. 2012 May 21; 301:122-40. PMID: 22342935.
      Citations: 49     Fields:    Translation:Humans
    58. Kelly P, Paulin F, Lamont D, Baker L, Clearly S, Exon D, Thompson A. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer. 2012 Feb 28; 106(5):955-61. PMID: 22294182.
      Citations: 14     Fields:    Translation:Humans
    59. Fong A, Shafiq J, Saunders C, Thompson A, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP. A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy. Breast. 2012 Aug; 21(4):562-9. PMID: 22297168.
      Citations: 2     Fields:    Translation:Humans
    60. Mullen R, Macaskill EJ, Khalil A, Elseedawy E, Brown DC, Lee AC, Purdie CA, Jordan LB, Thompson AM. Involved anterior margins after breast conserving surgery: is re-excision required? Eur J Surg Oncol. 2012 Apr; 38(4):302-6. PMID: 22285907.
      Citations: 9     Fields:    Translation:Humans
    61. Coley HM, Hatzimichael E, Blagden S, McNeish I, Thompson A, Crook T, Syed N. Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. Oncotarget. 2012 Jan; 3(1):78-83. PMID: 22289679.
      Citations: 13     Fields:    Translation:HumansAnimals
    62. Moussa O, Purdie C, Vinnicombe S, Thompson AM. Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility. Cancer Biomark. 2012-2013; 12(6):231-9. PMID: 23735943.
      Citations: 4     Fields:    Translation:Humans
    63. Lo Nigro C, Vivenza D, Monteverde M, Lattanzio L, Gojis O, Garrone O, Comino A, Merlano M, Quinlan PR, Syed N, Purdie CA, Thompson A, Palmieri C, Crook T. High frequency of complex TP53 mutations in CNS metastases from breast cancer. Br J Cancer. 2012 Jan 17; 106(2):397-404. PMID: 22187033.
      Citations: 10     Fields:    Translation:HumansCells
    64. Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat Rev. 2012 Oct; 38(6):708-14. PMID: 22178456.
      Citations: 52     Fields:    Translation:Humans
    65. Suttie SA, Nanthakumaran S, Mofidi R, Rapson T, Gilbert FJ, Thompson AM, Park KG. The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol. 2012 Feb; 38(2):157-65. PMID: 22154884.
      Citations: 3     Fields:    Translation:Humans
    66. Thompson AM. What is the future for surgical oncology? Br J Cancer. 2011 Nov 22; 105(11):1627. PMID: 22108552.
      Citations:    Fields:    Translation:Humans
    67. Rutgers E, Piccart-Gebhart MJ, Bogaerts J, Delaloge S, Veer LV, Rubio IT, Viale G, Thompson AM, Passalacqua R, Nitz U, Vindevoghel A, Pierga JY, Ravdin PM, Werutsky G, Cardoso F. The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase. Eur J Cancer. 2011 Dec; 47(18):2742-9. PMID: 22051734.
      Citations: 38     Fields:    Translation:Humans
    68. Waugh SA, Lerski RA, Bidaut L, Thompson AM. The influence of field strength and different clinical breast MRI protocols on the outcome of texture analysis using foam phantoms. Med Phys. 2011 Sep; 38(9):5058-66. PMID: 21978050.
      Citations: 14     Fields:    Translation:Humans
    69. McCowan C, Dewar JA, Thompson AM. Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the community. J Clin Oncol. 2011 Sep 01; 29(25):3492; author reply 3492; discussion 3492-3. PMID: 21768466.
      Citations:    Fields:    Translation:Humans
    70. Girardini JE, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, Means AR, Lozano G, Schneider C, Del Sal G. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell. 2011 Jul 12; 20(1):79-91. PMID: 21741598.
      Citations: 121     Fields:    Translation:HumansAnimalsCells
    71. Hadad S, Iwamoto T, Jordan L, Purdie C, Bray S, Baker L, Jellema G, Deharo S, Hardie DG, Pusztai L, Moulder-Thompson S, Dewar JA, Thompson AM. Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat. 2011 Aug; 128(3):783-94. PMID: 21655990.
      Citations: 98     Fields:    Translation:HumansCellsCTClinical Trials
    72. Watt SA, Pourreyron C, Purdie K, Hogan C, Cole CL, Foster N, Pratt N, Bourdon JC, Appleyard V, Murray K, Thompson AM, Mao X, Mein C, Bruckner-Tuderman L, Evans A, McGrath JA, Proby CM, Foerster J, Leigh IM, South AP. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene. 2011 Nov 17; 30(46):4666-77. PMID: 21602893.
      Citations: 20     Fields:    Translation:HumansCells
    73. McCowan C, Donnan PT, Dewar J, Thompson A, Fahey T. Identifying suspected breast cancer: development and validation of a clinical prediction rule. Br J Gen Pract. 2011 May; 61(586):e205-14. PMID: 21619744.
      Citations: 8     Fields:    Translation:Humans
    74. Martin AJ, Grant A, Ashfield AM, Palmer CN, Baker L, Quinlan PR, Purdie CA, Thompson AM, Jordan LB, Berg JN. FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype. BMC Res Notes. 2011 Mar 21; 4:72. PMID: 21418638.
      Citations: 10     Fields:    
    75. Scollay JM, Mullen R, McPhillips G, Thompson AM. Mortality associated with the treatment of gallstone disease: a 10-year contemporary national experience. World J Surg. 2011 Mar; 35(3):643-7. PMID: 21181471.
      Citations: 9     Fields:    Translation:Humans
    76. Moore HC, Johnston M, Nicol SM, Bourdon JC, Thompson AM, Hutvagner G, Fuller-Pace FV. An evolutionarily conserved, alternatively spliced, intron in the p68/DDX5 DEAD-box RNA helicase gene encodes a novel miRNA. RNA. 2011 Apr; 17(4):555-62. PMID: 21346006.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    77. Mullen R, Scollay JM, Hecht G, McPhillips G, Thompson AM. Death within 48 h--adverse events after general surgical procedures. Surgeon. 2012 Feb; 10(1):1-5. PMID: 22233549.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    78. Bourdon JC, Khoury MP, Diot A, Baker L, Fernandes K, Aoubala M, Quinlan P, Purdie CA, Jordan LB, Prats AC, Lane DP, Thompson AM. p53 mutant breast cancer patients expressing p53? have as good a prognosis as wild-type p53 breast cancer patients. Breast Cancer Res. 2011 Jan 20; 13(1):R7. PMID: 21251329.
      Citations: 38     Fields:    Translation:Humans
    79. Frieboes HB, Chaplain MA, Thompson AM, Bearer EL, Lowengrub JS, Cristini V. Physical oncology: a bench-to-bedside quantitative and predictive approach. Cancer Res. 2011 Jan 15; 71(2):298-302. PMID: 21224346.
      Citations: 25     Fields:    Translation:Humans
    80. Sturrock M, Terry AJ, Xirodimas DP, Thompson AM, Chaplain MA. Spatio-temporal modelling of the Hes1 and p53-Mdm2 intracellular signalling pathways. J Theor Biol. 2011 Mar 21; 273(1):15-31. PMID: 21184761.
      Citations: 14     Fields:    Translation:Cells
    81. Thompson AM. Deciding priorities in a clinical studies group. Breast Cancer Res. 2010 Dec 20; 12 Suppl 4:S22. PMID: 21172085.
      Citations:    Fields:    Translation:Humans
    82. Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Jordan L, Baker L, Thompson A. Quantitative shear wave ultrasound elastography: initial experience in solid breast masses. Breast Cancer Res. 2010; 12(6):R104. PMID: 21122101.
      Citations: 91     Fields:    Translation:Humans
    83. Coates PJ, Appleyard MV, Murray K, Ackland C, Gardner J, Brown DC, Adamson DJ, Jordan LB, Purdie CA, Munro AJ, Wright EG, Dewar JA, Thompson AM. Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft model. Cancer Res. 2010 Dec 01; 70(23):9808-15. PMID: 21084272.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    84. Thompson AM, Jordan LB, Quinlan P, Anderson E, Skene A, Dewar JA, Purdie CA. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). Breast Cancer Res. 2010; 12(6):R92. PMID: 21059212.
      Citations: 78     Fields:    Translation:Humans
    85. Phillips KA, Aldridge J, Ribi K, Sun Z, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast Cancer Res Treat. 2011 Feb; 126(1):221-6. PMID: 21046229.
      Citations: 24     Fields:    Translation:Humans
    86. Henry LA, Johnson DA, Sarrió D, Lee S, Quinlan PR, Crook T, Thompson AM, Reis-Filho JS, Isacke CM. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. Oncogene. 2011 Mar 03; 30(9):1046-58. PMID: 21042283.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    87. Rao B, van Leeuwen IM, Higgins M, Campbel J, Thompson AM, Lane DP, Lain S. Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget. 2010 Nov; 1(7):639-50. PMID: 21317459.
      Citations: 51     Fields:    Translation:HumansCells
    88. Ferraldeschi R, Howell SJ, Thompson AM, Newman WG. Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen. J Clin Oncol. 2010 Oct 10; 28(29):e584-5; author reply e586. PMID: 20823421.
      Citations: 4     Fields:    Translation:Humans
    89. Moore HC, Jordan LB, Bray SE, Baker L, Quinlan PR, Purdie CA, Thompson AM, Bourdon JC, Fuller-Pace FV. The RNA helicase p68 modulates expression and function of the ?133 isoform(s) of p53, and is inversely associated with ?133p53 expression in breast cancer. Oncogene. 2010 Dec 09; 29(49):6475-84. PMID: 20818423.
      Citations: 12     Fields:    Translation:HumansCells
    90. Thompson AM, Johnson A, Quinlan P, Hillman G, Fontecha M, Bray SE, Purdie CA, Jordan LB, Ferraldeschi R, Latif A, Hadfield KD, Clarke RB, Ashcroft L, Evans DG, Howell A, Nikoloff M, Lawrence J, Newman WG. Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87. PMID: 20809362.
      Citations: 24     Fields:    Translation:Humans
    91. Purdie CA, Baker L, Ashfield A, Chatterjee S, Jordan LB, Quinlan P, Adamson DJ, Dewar JA, Thompson AM. Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study. Br J Cancer. 2010 Aug 10; 103(4):475-81. PMID: 20664587.
      Citations: 12     Fields:    Translation:Humans
    92. Roy PG, Pratt N, Purdie CA, Baker L, Ashfield A, Quinlan P, Thompson AM. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer. 2010 Jul 15; 127(2):355-60. PMID: 19904758.
      Citations: 23     Fields:    Translation:Humans
    93. Lemée F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C, Lam E, Magdeleine E, Filleron T, Oumouhou N, Kaina B, Seki M, Grimal F, Lacroix-Triki M, Thompson A, Roché H, Bourdon JC, Wood RD, Hoffmann JS, Cazaux C. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci U S A. 2010 Jul 27; 107(30):13390-5. PMID: 20624954.
      Citations: 64     Fields:    Translation:HumansCells
    94. Kelly P, Appleyard V, Murray K, Paulin F, Lamont D, Baker L, Suttie S, Exon D, Thompson A. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. Br J Cancer. 2010 Jul 13; 103(2):232-8. PMID: 20551956.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    95. Coates P, Dewar J, Thompson AM. At last, a predictive and prognostic marker for radiotherapy? Breast Cancer Res. 2010; 12(3):106. PMID: 20497617.
      Citations: 4     Fields:    Translation:HumansCells
    96. Purdie CA, Jordan LB, McCullough JB, Edwards SL, Cunningham J, Walsh M, Grant A, Pratt N, Thompson AM. HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology. 2010 May; 56(6):702-7. PMID: 20546335.
      Citations: 15     Fields:    Translation:Humans
    97. Phillips KA, Ribi K, Sun Z, Stephens A, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J. Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast. 2010 Oct; 19(5):388-95. PMID: 20385495.
      Citations: 25     Fields:    Translation:Humans
    98. O'Neill MA, Mayer M, Murray KE, Rolim-Santos HM, Santos-Magalhães NS, Thompson AM, Appleyard VC. Does usnic acid affect microtubules in human cancer cells? Braz J Biol. 2010 Aug; 70(3):659-64. PMID: 20379653.
      Citations: 1     Fields:    Translation:HumansCells
    99. Thompson AM, Lane DP. p53 transcriptional pathways in breast cancer: the good, the bad and the complex. J Pathol. 2010 Mar; 220(4):401-3. PMID: 20044802.
      Citations: 5     Fields:    Translation:HumansCells
    100. Atrih A, Turnock D, Sellar G, Thompson A, Feuerstein G, Ferguson MA, Huang JT. Stoichiometric quantification of Akt phosphorylation using LC-MS/MS. J Proteome Res. 2010 Feb 05; 9(2):743-51. PMID: 19902931.
      Citations: 9     Fields:    Translation:HumansCells
    101. Sharma A, Crook T, Thompson A, Palmieri C. Surgical oncology: why biopsying metastatic breast cancer should be routine. Nat Rev Clin Oncol. 2010 Feb; 7(2):72-4. PMID: 20118974.
      Citations: 4     Fields:    Translation:Humans
    102. Baker L, Quinlan PR, Patten N, Ashfield A, Birse-Stewart-Bell LJ, McCowan C, Bourdon JC, Purdie CA, Jordan LB, Dewar JA, Wu L, Thompson AM. p53 mutation, deprivation and poor prognosis in primary breast cancer. Br J Cancer. 2010 Feb 16; 102(4):719-26. PMID: 20104224.
      Citations: 24     Fields:    Translation:Humans
    103. Liu Y, Appleyard MV, Coates PJ, Thompson AM. p53 and gamma radiation in the normal breast. Int J Radiat Biol. 2009 Nov; 85(11):1026-31. PMID: 19895279.
      Citations: 2     Fields:    Translation:HumansCells
    104. Chatterjee JS, Lee A, Anderson W, Baker L, Stevenson JH, Dewar JA, Thompson AM. Effect of postoperative radiotherapy on autologous deep inferior epigastric perforator flap volume after immediate breast reconstruction. Br J Surg. 2009 Oct; 96(10):1135-40. PMID: 19787763.
      Citations: 13     Fields:    Translation:Humans
    105. Hadad SM, Baker L, Quinlan PR, Robertson KE, Bray SE, Thomson G, Kellock D, Jordan LB, Purdie CA, Hardie DG, Fleming S, Thompson AM. Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer. 2009 Sep 01; 9:307. PMID: 19723334.
      Citations: 59     Fields:    Translation:HumansCells
    106. Shah R, Smith P, Purdie C, Quinlan P, Baker L, Aman P, Thompson AM, Crook T. The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer. 2009 May 19; 100(10):1687-96. PMID: 19436308.
      Citations: 19     Fields:    Translation:HumansCells
    107. Buchanan D, Milroy R, Baker L, Thompson AM, Levack PA. Perceptions of anxiety in lung cancer patients and their support network. Support Care Cancer. 2010 Jan; 18(1):29-36. PMID: 19350285.
      Citations: 9     Fields:    Translation:Humans
    108. Appleyard MV, O'Neill MA, Murray KE, Paulin FE, Bray SE, Kernohan NM, Levison DA, Lane DP, Thompson AM. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int J Cancer. 2009 Jan 15; 124(2):465-72. PMID: 19003963.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    109. McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, Fahey TP. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer. 2008 Dec 02; 99(11):1763-8. PMID: 18985046.
      Citations: 90     Fields:    Translation:Humans
    110. Staples OD, Hollick JJ, Campbell J, Higgins M, McCarthy AR, Appleyard V, Murray KE, Baker L, Thompson A, Ronseaux S, Slawin AM, Lane DP, Westwood NJ, Lain S. Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screen. . 2008 Nov 01; 7(21):3417-27. PMID: 18971638.
    111. Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA. A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res. 2008; 10(5):R88. PMID: 18928543.
      Citations: 21     Fields:    Translation:Humans
    112. Paulin FE, O'Neill M, McGregor G, Cassidy A, Ashfield A, Ali CW, Munro AJ, Baker L, Purdie CA, Lane DP, Thompson AM. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism. BMC Cancer. 2008 Oct 01; 8:281. PMID: 18828900.
      Citations: 24     Fields:    Translation:Humans
    113. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008 May; 95(5):547-54. PMID: 18386775.
      Citations: 19     Fields:    Translation:Humans
    114. Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M, McCarthy A, Appleyard V, Murray KE, Baker L, Thompson A, Mathers J, Holland SJ, Stark MJ, Pass G, Woods J, Lane DP, Westwood NJ. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell. 2008 May; 13(5):454-63. PMID: 18455128.
      Citations: 172     Fields:    Translation:HumansAnimalsCells
    115. Cardoso F, Saghatchian M, Thompson A, Rutgers E. Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2008 Apr 20; 26(12):2058-9; author reply 2060-1. PMID: 18421063.
      Citations: 4     Fields:    Translation:Humans
    116. Hadad SM, Appleyard V, Thompson AM. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2009 Mar; 114(2):391. PMID: 18421577.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    117. Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, Steel M, Streuli C. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008; 10(2):R26. PMID: 18371194.
      Citations: 37     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    118. Hadad SM, Fleming S, Thompson AM. Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol. 2008 Jul; 67(1):1-7. PMID: 18343152.
      Citations: 60     Fields:    Translation:HumansAnimalsCells
    119. Song C, Appleyard V, Murray K, Frank T, Sibbett W, Cuschieri A, Thompson A. Thermographic assessment of tumor growth in mouse xenografts. Int J Cancer. 2007 Sep 01; 121(5):1055-8. PMID: 17487841.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    120. Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, Altman DG. Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer. 2007 Aug 15; 7:160. PMID: 17697367.
      Citations: 27     Fields:    Translation:Humans
    121. Gray LJ, Bjelogrlic P, Appleyard VC, Thompson AM, Jolly CE, Lain S, Herrington CS. Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenes. Int J Cancer. 2007 Jun 01; 120(11):2317-24. PMID: 17290384.
      Citations: 6     Fields:    Translation:HumansCells
    122. Hadad SM, Vaidya JS, Baker L, Koh HC, Heron TP, Hussain K, Thompson AM. Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis. World J Surg. 2007 Jun; 31(6):1298-01; discussion 1302-3. PMID: 17483986.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    123. Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007 May; 94(5):578-84. PMID: 17410636.
      Citations: 15     Fields:    Translation:Humans
    124. Vaidya JS, Baum M, Tobias JS, Massarut S, Wenz F, Murphy O, Hilaris B, Houghton J, Saunders C, Corica T, Roncadin M, Kraus-Tiefenbacher U, Melchaert F, Keshtgar M, Sainsbury R, Douek M, Harrison E, Thompson A, Joseph D. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1335-8. PMID: 17084562.
      Citations: 15     Fields:    Translation:Humans
    125. Smith TA, Sharma RI, Thompson AM, Paulin FE. Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro. J Nucl Med. 2006 Sep; 47(9):1525-30. PMID: 16954562.
      Citations: 13     Fields:    Translation:HumansCells
    126. Rodger A, Stebbing J, Thompson AM. Breast cancer (non-metastatic). Clin Evid. 2006 Jun; (15):2360-92. PMID: 16973090.
      Citations: 2     Fields:    Translation:Humans
    127. Roy PG, Thompson AM. Cyclin D1 and breast cancer. Breast. 2006 Dec; 15(6):718-27. PMID: 16675218.
      Citations: 78     Fields:    Translation:Humans
    128. Phull PS, Salmon CA, Park KG, Rapson T, Thompson AM, Gilbert FJ. Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy--data from the Scottish audit of gastric and oesophageal cancer. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):229-33. PMID: 16393301.
      Citations: 2     Fields:    Translation:Humans
    129. Thompson A, Stonebridge PA, Spigelman AD. Surgical accountability: a framework for trust and change. Med J Aust. 2005 Nov 21; 183(10):500. PMID: 16296959.
      Citations: 1     Fields:    Translation:Humans
    130. Thompson AM, Ashraf Z, Burton H, Stonebridge PA. Mapping changes in surgical mortality over 9 years by peer review audit. Br J Surg. 2005 Nov; 92(11):1449-52. PMID: 15997442.
      Citations: 7     Fields:    Translation:Humans
    131. Mayer M, O'Neill MA, Murray KE, Santos-Magalhães NS, Carneiro-Leão AM, Thompson AM, Appleyard VC. Usnic acid: a non-genotoxic compound with anti-cancer properties. Anticancer Drugs. 2005 Sep; 16(8):805-9. PMID: 16096427.
      Citations: 8     Fields:    Translation:HumansCells
    132. Nanthakumaran S, Fernandes E, Thompson AM, Rapson T, Gilbert FJ, Park KG. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. Eur J Surg Oncol. 2005 Dec; 31(10):1141-4. PMID: 16111855.
      Citations: 10     Fields:    Translation:Humans
    133. Vaidya JS, Dewar JA, Brown DC, Thompson AM. A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday use. Breast Cancer Res. 2005; 7(5):225-7. PMID: 16168143.
      Citations: 2     Fields:    Translation:Humans
    134. Thompson AM, Ritchie W, Stonebridge PA. Could sequential individual peer reviewed mortality audit data be used in appraisal? Surgeon. 2005 Aug; 3(4):288-92. PMID: 16121777.
      Citations: 3     Fields:    Translation:Humans
    135. Thompson AM, Stonebridge PA. Building a framework for trust: critical event analysis of deaths in surgical care. BMJ. 2005 May 14; 330(7500):1139-42. PMID: 15891231.
      Citations: 15     Fields:    Translation:Humans
    136. Thompson AM. Microarray technology for surgeons. Br J Surg. 2005 Apr; 92(4):387-8. PMID: 15786426.
      Citations:    Fields:    Translation:Humans
    137. Liu HP, Thompson AM, Macleod KF. A novel form of pRb expressed during normal myelopoiesis and in tumour-associated macrophages. Cell Prolif. 2005 Feb; 38(1):13-24. PMID: 15679863.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    138. Appleyard VC, O'Neill MA, Murray KE, Bray SE, Thomson G, Kernohan NM, Varani J, Zhang J, Thompson AM. Activity of MDI-301, a novel synthetic retinoid, in xenografts. Anticancer Drugs. 2004 Nov; 15(10):991-6. PMID: 15514569.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    139. Ritchie MR, Morton MS, Thompson AM, Deighton N, Blake A, Cummings JH, Steel CM. Investigation of the reliability of 24 h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes. Eur J Clin Nutr. 2004 Sep; 58(9):1286-9. PMID: 15054404.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    140. Stonebridge PA, Buckley C, Thompson A, Dick J, Hunter G, Chudek JA, Houston JG, Belch JJ. Non spiral and spiral (helical) flow patterns in stenoses. In vitro observations using spin and gradient echo magnetic resonance imaging (MRI) and computational fluid dynamic modeling. Int Angiol. 2004 Sep; 23(3):276-83. PMID: 15765044.
      Citations: 2     Fields:    Translation:Humans
    141. Wells M, Harrow A, Donnan P, Davey P, Devereux S, Little G, McKenna E, Wood R, Chen R, Thompson A. Patient, carer and health service outcomes of nurse-led early discharge after breast cancer surgery: a randomised controlled trial. Br J Cancer. 2004 Aug 16; 91(4):651-8. PMID: 15238983.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    142. Spruce BA, Campbell LA, McTavish N, Cooper MA, Appleyard MV, O'Neill M, Howie J, Samson J, Watt S, Murray K, McLean D, Leslie NR, Safrany ST, Ferguson MJ, Peters JA, Prescott AR, Box G, Hayes A, Nutley B, Raynaud F, Downes CP, Lambert JJ, Thompson AM, Eccles S. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res. 2004 Jul 15; 64(14):4875-86. PMID: 15256458.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    143. Thompson AM, Rapson T, Gilbert FJ, Park KG. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc. 2004 Aug; 18(8):1257-62. PMID: 15164283.
      Citations: 6     Fields:    Translation:Humans
    144. Thompson AM. Dissecting the molecular mechanisms of human cancer: translating laboratory advances into clinical practice. Surgeon. 2004 Feb; 2(1):1-6. PMID: 15570800.
      Citations:    Fields:    Translation:HumansCells
    145. Thompson AM, Wright DJ, Murray W, Ritchie GL, Burton HD, Stonebridge PA. Analysis of 153 deaths after upper gastrointestinal endoscopy: room for improvement? Surg Endosc. 2004 Jan; 18(1):22-5. PMID: 14625742.
      Citations: 13     Fields:    Translation:Humans
    146. Liem AA, Appleyard MV, O'Neill MA, Hupp TR, Chamberlain MP, Thompson AM. Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines. Br J Cancer. 2003 Apr 22; 88(8):1281-4. PMID: 12698197.
      Citations: 4     Fields:    Translation:HumansCells
    147. Hislop RG, Pratt N, Stocks SC, Steel CM, Sales M, Goudie D, Robertson A, Thompson AM. Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br J Surg. 2002 Dec; 89(12):1581-6. PMID: 12445070.
      Citations: 5     Fields:    Translation:HumansCells
    148. Liem AA, Chamberlain MP, Wolf CR, Thompson AM. The role of signal transduction in cancer treatment and drug resistance. Eur J Surg Oncol. 2002 Sep; 28(6):679-84. PMID: 12359208.
      Citations: 3     Fields:    Translation:HumansCells
    149. Thompson AM, Park KG. Diagnosis and management of a mediastinal leak following radical oesophagectomy (Br J Surg 2001; 88: 1346-51). Br J Surg. 2002 Jun; 89(6):810-1; discussion 811. PMID: 12028004.
      Citations:    Fields:    Translation:Humans
    150. Barrett EC, Kat CC. Sterilisation of Elastoplast adhesive tape. Br J Plast Surg. 2002 Mar; 55(2):178-9. PMID: 11987976.
      Citations:    Fields:    Translation:HumansPHPublic Health
    151. Nicoll G, Crichton DN, McDowell HE, Kernohan N, Hupp TR, Thompson AM. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer. 2001 Dec 14; 85(12):1878-82. PMID: 11747329.
      Citations: 13     Fields:    Translation:HumansCells
    152. Ball HM, Hupp TR, Ziyaie D, Purdie CA, Kernohan NM, Thompson AM. Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring. Br J Cancer. 2001 Oct 19; 85(8):1102-5. PMID: 11710820.
      Citations:    Fields:    Translation:Humans
    153. Riches AC, Bryant PE, Steel CM, Gleig A, Robertson AJ, Preece PE, Thompson AM. Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br J Cancer. 2001 Oct 19; 85(8):1157-61. PMID: 11710829.
      Citations: 17     Fields:    Translation:HumansCells
    154. Stocks SC, Pratt N, Sales M, Johnston DA, Thompson AM, Carey FA, Kernohan NM. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas. Genes Chromosomes Cancer. 2001 Sep; 32(1):50-8. PMID: 11477661.
      Citations: 6     Fields:    Translation:HumansCells
    155. Ziyaie D, Hupp TR, Thompson AM. P53 and breast cancer. Breast. 2000 Oct; 9(5):239-46. PMID: 14732173.
      Citations: 9     Fields:    
    156. McGugan E, Burton H, Nixon SJ, Thompson AM. Deaths following hernia surgery: room for improvement. J R Coll Surg Edinb. 2000 Jun; 45(3):183-6. PMID: 10881486.
      Citations: 14     Fields:    Translation:Humans
    157. Adam DJ, Thompson AM, Cameron EW, Walker WS. Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg. 1999 Dec; 86(12):1589-90. PMID: 10636707.
      Citations:    Fields:    Translation:Humans
    158. Craig AL, Blaydes JP, Burch LR, Thompson AM, Hupp TR. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation. Oncogene. 1999 Nov 04; 18(46):6305-12. PMID: 10597229.
      Citations: 10     Fields:    Translation:HumansCells
    159. Craig AL, Burch L, Vojtesek B, Mikutowska J, Thompson A, Hupp TR. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem J. 1999 Aug 15; 342 ( Pt 1):133-41. PMID: 10432310.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    160. Stonebridge PA, Thompson AM, Nixon SJ. Completion of the journey of care: Scottish Audit of Surgical Mortality (SASM). J R Coll Surg Edinb. 1999 Jun; 44(3):185-6. PMID: 10372491.
      Citations: 2     Fields:    Translation:Humans
    161. Thompson AM. Axillary node clearance for breast cancer. J R Coll Surg Edinb. 1999 Apr; 44(2):111-6. PMID: 10230206.
      Citations: 2     Fields:    Translation:Humans
    162. Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg. 1998 Nov; 85(11):1460-7. PMID: 9823903.
      Citations: 34     Fields:    Translation:Humans
    163. O'Neill M, Campbell SJ, Save V, Thompson AM, Hall PA. An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170. J Pathol. 1998 Nov; 186(3):254-61. PMID: 10211113.
      Citations: 3     Fields:    Translation:Humans
    164. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res. 1998 Mar 01; 58(5):1004-12. PMID: 9500463.
      Citations: 17     Fields:    Translation:HumansCells
    165. Thompson AM, Crichton DN, Elton RA, Clay MF, Chetty U, Steel CM. Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up. Br J Cancer. 1998 Mar; 77(5):797-800. PMID: 9514060.
      Citations: 2     Fields:    Translation:HumansCells
    166. Thompson AM, Elton RA, Hawkins RA, Chetty U, Steel CM. PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer. Br J Cancer. 1998; 77(3):492-6. PMID: 9472649.
      Citations: 2     Fields:    Translation:Humans
    167. Nagy J, Thompson AM. Laparoscopic and conventional repair of groin disruption in sportsmen. Br J Surg. 1997 Aug; 84(8):1172. PMID: 9278680.
      Citations:    Fields:    Translation:Humans
    168. Thompson AM, Park KG, Kelly DR, MacNamara I, Munro A. Training for minor surgery in general practice: is it adequate? J R Coll Surg Edinb. 1997 Apr; 42(2):89-91. PMID: 9114676.
      Citations: 3     Fields:    Translation:Humans
    169. Adam DJ, Thompson AM, Walker WS, Cameron EW. Oesophagogastrectomy for iatrogenic perforation of oesophageal and cardia carcinoma. Br J Surg. 1996 Oct; 83(10):1429-32. PMID: 8944464.
      Citations: 3     Fields:    Translation:Humans
    170. MacCallum J, Keen JC, Bartlett JM, Thompson AM, Dixon JM, Miller WR. Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy. Br J Cancer. 1996 Aug; 74(3):474-8. PMID: 8695368.
      Citations: 5     Fields:    Translation:Humans
    171. Potter MA, Thompson AM. Radiotherapy and the management of the axilla in early breast cancer. Br J Surg. 1995 Jul; 82(7):1001. PMID: 7648085.
      Citations:    Fields:    Translation:Humans
    172. Thompson AM, Steel CM, Chetty U, Dixon JM, Carter DC. Transforming growth factor beta 1 is unlikely to mediate p53 abnormalities in breast cancer. Br J Surg. 1995 Feb; 82(2):210-1. PMID: 7749692.
      Citations: 1     Fields:    Translation:Humans
    173. Hubbard AL, Doris CP, Thompson AM, Chetty U, Anderson TJ. Critical determination of the frequency of c-erbB-2 amplification in breast cancer. Br J Cancer. 1994 Sep; 70(3):434-9. PMID: 7915911.
      Citations: 1     Fields:    Translation:HumansCells
    174. Adam D, Thompson AM. Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg. 1994 Jul; 81(7):1081. PMID: 7832847.
      Citations:    Fields:    Translation:Humans
    175. MacCallum J, Bartlett JM, Thompson AM, Keen JC, Dixon JM, Miller WR. Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer. 1994 Jun; 69(6):1006-9. PMID: 8198961.
      Citations: 18     Fields:    Translation:Humans
    176. Dixon JM, Thompson AM. Provision and acceptability of day case breast biopsy: an audit of current practice. Ann R Coll Surg Engl. 1993 Nov; 75(6):451; author reply 452. PMID: 8285559.
      Citations:    Fields:    Translation:Humans
    177. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer. 1993 Jul; 68(1):64-8. PMID: 8318422.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    178. Radford DM, Fair K, Thompson AM, Ritter JH, Holt M, Steinbrueck T, Wallace M, Wells SA, Donis-Keller HR. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res. 1993 Jul 01; 53(13):2947-9. PMID: 8391383.
      Citations: 18     Fields:    Translation:HumansCells
    179. Thompson AM, Hawkins RA, Elton RA, Steel CM, Chetty U, Carter DC. pS2 is an independent factor of good prognosis in primary breast cancer. Br J Cancer. 1993 Jul; 68(1):93-6. PMID: 8318427.
      Citations: 6     Fields:    Translation:Humans
    180. Holme TC, Reis MM, Thompson A, Robertson A, Parham D, Hickman P, Preece PE. Is mammographic microcalcification of biological significance? Eur J Surg Oncol. 1993 Jun; 19(3):250-3. PMID: 8390947.
      Citations: 8     Fields:    Translation:Humans
    181. Thompson AM, Park KG, Kerr F, Munro A. Safety of fibreoptic endoscopy: analysis of cardiorespiratory events. Br J Surg. 1992 Oct; 79(10):1046-9. PMID: 1422716.
      Citations: 3     Fields:    Translation:Humans
    182. Thompson AM. How safe is Scottish hot air? BMJ. 1992 Sep 19; 305(6855):691. PMID: 1393113.
      Citations:    Fields:    Translation:Humans
    183. Wong PS, Wright JE, White PA. Perforation of gloves. BMJ. 1992 May 16; 304(6837):1311. PMID: 1606445.
      Citations:    Fields:    Translation:Humans
    184. Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ. Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer. 1992 Apr; 65(4):527-8. PMID: 1562462.
      Citations: 17     Fields:    Translation:Humans
    185. Thompson AM, Dixon JM. Familial breast cancer. J R Coll Surg Edinb. 1992 Apr; 37(2):136. PMID: 1377260.
      Citations: 1     Fields:    Translation:Humans
    186. Johnstone AJ, John TG, Thompson AM, Charles MH, Dixon JM. PDS II (polydioxanone) is the monofilament suture of choice for subcuticular wound closure following breast biopsy. J R Coll Surg Edinb. 1992 Apr; 37(2):94-6. PMID: 1377271.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    187. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer. 1992 Feb 20; 50(4):528-32. PMID: 1537617.
      Citations: 30     Fields:    Translation:HumansCells
    188. Dixon JM, Thompson AM. Effective surgical treatment for mammary duct fistula. Br J Surg. 1991 Oct; 78(10):1185-6. PMID: 1958980.
      Citations: 3     Fields:    Translation:Humans
    189. Johnstone AJ, Thompson AM, Charles M, John TG, Dixon JM. Wound compression pads are of no value after local anaesthetic breast biopsy. Ann R Coll Surg Engl. 1991 Sep; 73(5):303-4. PMID: 1929132.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    190. Thompson AM, Kerr DJ, Steel CM. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br J Cancer. 1991 Apr; 63(4):609-14. PMID: 2021547.
      Citations: 16     Fields:    Translation:HumansAnimals
    191. Steel M, Thompson A, Clayton J. Genetic aspects of breast cancer. Br Med Bull. 1991 Apr; 47(2):504-18. PMID: 1933230.
      Citations: 5     Fields:    Translation:Humans
    192. Prosser J, Thompson AM, Cranston G, Evans HJ. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene. 1990 Oct; 5(10):1573-9. PMID: 2250913.
      Citations: 47     Fields:    Translation:HumansCells
    193. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, et al. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 1990 Sep 29; 336(8718):761-3. PMID: 1976143.
      Citations: 47     Fields:    Translation:HumansCells
    194. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990 Aug 30; 346(6287):866-8. PMID: 2392154.
      Citations: 361     Fields:    Translation:HumansCells
    195. Thompson AM, Steel CM, Foster ME, Kerr D, Paterson D, Deane D, Hawkins RA, Carter DC, Evans HJ. Gene expression in oestrogen-dependent human breast cancer xenograft tumours. Br J Cancer. 1990 Jul; 62(1):78-84. PMID: 2390487.
      Citations: 4     Fields:    Translation:AnimalsCells
    196. Thompson AM, Chetty U. Appraisal of breast reconstruction with the tissue expansion technique. J R Coll Surg Edinb. 1990 Feb; 35(1):4-6. PMID: 2342010.
      Citations:    Fields:    Translation:Humans
    197. Mackay J, Thompson AM, Coles C, Steel CM. Molecular lesions in breast cancer. Int J Cancer Suppl. 1990; 5:47-50. PMID: 2258265.
      Citations: 1     Fields:    Translation:Humans
    198. Thompson AM, Steel CM, Chetty U, Hawkins RA, Miller WR, Carter DC, Forrest AP, Evans HJ. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer. 1990 Jan; 61(1):74-8. PMID: 2137009.
      Citations: 28     Fields:    Translation:HumansCells
    199. Thompson AM, Steel CM, Carter DC. Recessive mutation, chromosome deletion and cancer. Br J Surg. 1989 Jul; 76(7):765. PMID: 2765824.
      Citations:    Fields:    Translation:Humans
    200. Seidelin PH, Stolarek IH, Thompson AM. Central venous catheterization and fatal air embolism. Br J Hosp Med. 1987 Nov; 38(5):438-9. PMID: 3318980.
      Citations: 3     Fields:    Translation:Humans
    201. Evidence for the multistep theory of carcinogenesis in human breast cancer. The Breast. 1:29-34.
    202. Beyond detection. Physical Biology. 9.
    203. Classification of breast-tissue microarray spots using colour and local invariants. 999-1002.
    204. Structural chromosome analysis in peripheral blood lymphocytes of individuals belonging to breast cancer pedigrees suggest an association of genetic instability with a proportion of breast cancer in families not linked to the BRCA-1 gene. The Breast. 3:209-214.
    205. Telomere loss and cancer [9]. Nature. 350:197.
    206. Viewpoint. European Journal of Surgical Oncology. 42:994-998.
    207. A hard pill to swallow. BMJ Open. 4.
    208. Reduction in gastric cancer surgical mortality over 10 years. Annals of Medicine and Surgery. 3:26-30.
    209. eLife. 5.
    210. Accelerated Partial Breast Irradiation. Practical Radiation Oncology.
    211. A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer. BMC Cancer. 16.
    212. Inspire. 587-590.
    213. Phase II randomized preoperative window-of-opportunity study of the PI3K inhibitor pictilisib plus anastrozole compared with anastrozole alone in patients with estrogen receptor-positive breast cancer. Journal of Clinical Oncology. 34:1987-1994.
    214. Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer. Oncotarget. 6:21685-21703.
    215. MAGE-A Cancer/testis antigens inhibit MDM2 ubiquitylation function and promote increased levels of MDM4. PLoS One. 10.
    216. Genetic risk factors in breast cancer. Advances in Breast Cancer. 3:27-32.
    217. Authors' reply. British Journal of Surgery. 95:1305.
    218. HER2 testing for breast carcinoma. Journal of Clinical Pathology. 67:161-167.
    219. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 534:47-54.
    220. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours (Oncogene (1990) 5 (1573-1579)). Oncogene. 6:2161.
    221. Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis (World Journal of Surgery 31, 6, DOI. World Journal of Surgery. 32:2747.
    222. To a 20th century haggis. Scottish Medical Journal. 42:22.
    223. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients. Annals of Surgical Oncology. 23:1508-1514.
    224. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays. British Journal of Cancer. 113:1075-1080.
    225. Correction. Cancer Research. 71:2024.
    226. Erratum. Genome Research. 26:717.
    227. Spironolactone use and risk of incident cancers. British Journal of Clinical Pharmacology.
    228. p53 and breast cancer. The Breast. 2:8-10.
    229. DCIS and sentinel lymph node biopsy. 117-124.
    230. The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers. Cell Cycle. 13:1413-1423.
    231. Arm morbidity after breast conservation and axillary therapy. The Breast. 4:273-276.
    232. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer. Annals of Surgical Oncology. 1-9.
    233. The topography of mutational processes in breast cancer genomes. Nature Communications. 7.
    234. The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer. Oncogene.
    235. Intraoperative Radiotherapy. Current Breast Cancer Reports. 7:15-21.
    236. Mathematical oncology. Current Breast Cancer Reports. 2:121-129.
    237. Postoperative bacteriological wound swabs for the prediction of wound infection. Surgical Research Communications. 6:199-203.
    238. The radiological features, Diagnosis and management of screen-detected lobular neoplasia of the breast. Breast. 27:109-115.
    239. Less Remains Better. Annals of Surgical Oncology. 22:4-6.
    240. Reply to R.F. Sweis et al. Journal of Clinical Oncology. 35:261-262.
    241. Chapter III. 2. Molecular lesions in breast cancer. International Journal of Cancer. 46:47-50.
    242. Scoring of breast tissue microarray spots through ordinal regression. 243-248.
    243. In vivo rates of mucosal protein synthesis in patients with Barrett's oesophagus. Diseases of the Esophagus. 7:107-111.
    244. Surgery for gastric adenocarcinoma. Journal of the Royal College of Surgeons of Edinburgh. 43:213-214.
    245. Tumor localization in tissue microarrays using rotation invariant superpixel pyramids. 1292-1295.
    246. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Research. 25:814-824.
    247. Genetics and Molecular Biology of Breast Cancer, 2-6 September 1992. Cold Spring Harbor Laboratory, New York. The Breast. 1:211.
    248. Evaluation of a breast mass. 105-119.
    249. Development of 18F-fluorinatable dendrons and their application to cancer cell targeting. New Journal of Chemistry. 35:2496-2502.
    250. An analysis and hypothesis generation platform for heterogeneous cancer databases. 59-70.
    251. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nature Communications. 7.
    252. EUSOMA - Biology of breast cancer, 10-11 November 1994, London, UK. The Breast. 4:156-159.
    253. Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment. Histopathology. 67:279-293.
    THOMPSON's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (738)
    Co-Authors (23)
    Similar People (60)
    Same Department Expand Description